Cargando…
African American participation in cancer clinical trials
BACKGROUND: According to the Food and Drug Administration, African Americans (AAs) have been habitually underrepresented in cancer clinical trials (CCTs). This under-enrolment has contributed to cancer disparities despite the implementation of policies to improve AA accrual. This systematic review a...
Autores principales: | Swaby, Jordan, Kaninjing, Ernie, Ogunsanya, Motolani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580719/ https://www.ncbi.nlm.nih.gov/pubmed/34824630 http://dx.doi.org/10.3332/ecancer.2021.1307 |
Ejemplares similares
-
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
por: Arriens, Cristina, et al.
Publicado: (2020) -
Quality of Life Among Black Prostate Cancer Survivors: An Integrative Review
por: Dickey, Sabrina L., et al.
Publicado: (2018) -
Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors
por: Kumar, Gaurav, et al.
Publicado: (2022) -
Barriers and facilitators to accessing and utilising post-treatment psychosocial support by Black men treated for prostate cancer—a systematic review and qualitative synthesis
por: Bamidele, Olufikayo O., et al.
Publicado: (2022) -
Knowledge of Prostate Cancer and Screening Among Young Multiethnic Black Men
por: Ogunsanya, Motolani E., et al.
Publicado: (2017)